| Product Code: ETC13174380 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Targeted Sequencing and Resequencing Market was valued at USD 2.7 Billion in 2024 and is expected to reach USD 4.2 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
The Global Targeted Sequencing and Resequencing Market is experiencing significant growth due to the increasing demand for personalized medicine and precision healthcare solutions. Targeted sequencing allows for the precise analysis of specific regions of interest within the genome, enabling researchers and clinicians to identify genetic variations associated with diseases and tailor treatments accordingly. Resequencing, on the other hand, involves mapping and sequencing an individual`s entire genome to identify variations compared to a reference genome. The market is driven by advancements in sequencing technologies, decreasing costs of sequencing, and growing applications in areas such as oncology, agriculture, and microbiology. Key players in the market include Illumina, Thermo Fisher Scientific, Qiagen, and Roche. With ongoing developments in bioinformatics and data analysis tools, the Global Targeted Sequencing and Resequencing Market is expected to continue its expansion in the coming years.
The Global Targeted Sequencing and Resequencing Market is experiencing rapid growth due to advancements in next-generation sequencing technologies and increasing applications in precision medicine and agricultural genomics. Key trends include a shift towards cloud-based data analysis solutions, rising adoption of liquid biopsy for cancer diagnostics, and integration of artificial intelligence for data interpretation. Opportunities in the market lie in the development of novel targeted sequencing panels for rare disease diagnostics, expansion of sequencing applications in non-invasive prenatal testing, and increasing collaborations between pharmaceutical companies and sequencing service providers for drug development. Additionally, the emergence of personalized medicine and the growing demand for companion diagnostics are driving the market forward, presenting immense growth potential for companies operating in the targeted sequencing and resequencing space.
The Global Targeted Sequencing and Resequencing Market faces several challenges, including high costs associated with equipment and reagents, data analysis complexities, and the need for skilled personnel to interpret results accurately. Additionally, ensuring the accuracy and reliability of sequencing data poses a significant challenge due to factors such as sample quality variation and potential errors in sequencing technology. Moreover, regulatory hurdles related to data privacy and usage restrictions can hinder market growth and adoption. The rapidly evolving nature of sequencing technologies also presents a challenge in keeping up with advancements and incorporating new techniques effectively. Overall, overcoming these challenges will be crucial for the market to realize its full potential and drive innovation in precision medicine and genomics research.
The Global Targeted Sequencing and Resequencing Market is primarily driven by the increasing demand for personalized medicine and precision healthcare solutions. Advances in sequencing technologies have made targeted sequencing and resequencing more cost-effective and efficient, driving adoption across research institutions and healthcare facilities. Additionally, the growing prevalence of genetic disorders and chronic diseases has fueled the need for accurate and comprehensive genetic testing, further propelling market growth. Moreover, the expanding applications of targeted sequencing in oncology, agriculture, and microbiology are creating new opportunities for market expansion. Government initiatives supporting genomic research and the development of innovative sequencing platforms are also contributing to the market`s growth trajectory. Overall, the increasing focus on genomics-driven healthcare solutions and the rising investments in research and development activities are key drivers shaping the Global Targeted Sequencing and Resequencing Market.
Government policies related to the Global Targeted Sequencing and Resequencing Market vary by country and region. In general, governments are increasingly recognizing the importance of genomics technologies for healthcare, agriculture, and environmental research, leading to investments in research and development, infrastructure, and regulatory frameworks to support the growth of the market. Policies may include funding for genomics research projects, initiatives to build genomic data repositories, regulations on data privacy and ethical considerations, and support for the integration of genomics into healthcare systems. Additionally, some governments are promoting collaborations between academia, industry, and government agencies to accelerate innovation in genomics technologies. Overall, government policies aim to facilitate the development and adoption of targeted sequencing and resequencing technologies to drive advancements in various sectors and improve overall societal well-being.
The Global Targeted Sequencing and Resequencing Market is poised for significant growth in the coming years due to advancements in technology, increasing demand for precision medicine, and expanding applications in research and clinical diagnostics. The market is expected to be driven by the rising prevalence of genetic disorders, cancer, and infectious diseases, leading to a growing need for accurate and efficient sequencing solutions. Additionally, the decreasing costs of sequencing technologies and the availability of high-throughput platforms are likely to fuel market expansion. Furthermore, the integration of artificial intelligence and machine learning in data analysis is expected to enhance the efficiency and accuracy of sequencing processes. Overall, the Global Targeted Sequencing and Resequencing Market is forecasted to experience robust growth opportunities and innovation in the foreseeable future.
In the Global Targeted Sequencing and Resequencing Market, Asia is expected to witness significant growth due to increasing investments in research and development activities, particularly in countries like China and India. North America is anticipated to dominate the market, driven by the presence of key market players, advanced healthcare infrastructure, and government initiatives promoting precision medicine. Europe is projected to exhibit steady growth owing to the rising adoption of personalized medicine and advancements in sequencing technologies. The Middle East and Africa region is likely to experience moderate growth due to improving healthcare infrastructure and increasing focus on genomics research. Latin America is expected to show promising growth opportunities with the rising prevalence of genetic disorders and increasing awareness about the benefits of targeted sequencing and resequencing technologies.
Global Targeted Sequencing and Resequencing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Targeted Sequencing and Resequencing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Global Targeted Sequencing and Resequencing Market - Industry Life Cycle |
3.4 Global Targeted Sequencing and Resequencing Market - Porter's Five Forces |
3.5 Global Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Targeted Sequencing and Resequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Targeted Sequencing and Resequencing Market Trends |
6 Global Targeted Sequencing and Resequencing Market, 2021 - 2031 |
6.1 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By DNA-based Targeted Sequencing, 2021 - 2031 |
6.1.3 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By RNA-based Targeted Sequencing, 2021 - 2031 |
6.2 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By Clinical Application, 2021 - 2031 |
6.2.3 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By Plant and Animal Sciences, 2021 - 2031 |
6.2.4 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By Drug Development, 2021 - 2031 |
6.2.5 Global Targeted Sequencing and Resequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Targeted Sequencing and Resequencing Market, Overview & Analysis |
7.1 North America Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 - 2031 |
7.2 North America Targeted Sequencing and Resequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Targeted Sequencing and Resequencing Market, Overview & Analysis |
8.1 Latin America (LATAM) Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Targeted Sequencing and Resequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Targeted Sequencing and Resequencing Market, Overview & Analysis |
9.1 Asia Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Targeted Sequencing and Resequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Targeted Sequencing and Resequencing Market, Overview & Analysis |
10.1 Africa Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Targeted Sequencing and Resequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Targeted Sequencing and Resequencing Market, Overview & Analysis |
11.1 Europe Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Targeted Sequencing and Resequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Targeted Sequencing and Resequencing Market, Overview & Analysis |
12.1 Middle East Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Targeted Sequencing and Resequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Targeted Sequencing and Resequencing Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Targeted Sequencing and Resequencing Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Targeted Sequencing and Resequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Targeted Sequencing and Resequencing Market Key Performance Indicators |
14 Global Targeted Sequencing and Resequencing Market - Export/Import By Countries Assessment |
15 Global Targeted Sequencing and Resequencing Market - Opportunity Assessment |
15.1 Global Targeted Sequencing and Resequencing Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Targeted Sequencing and Resequencing Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Targeted Sequencing and Resequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Targeted Sequencing and Resequencing Market - Competitive Landscape |
16.1 Global Targeted Sequencing and Resequencing Market Revenue Share, By Companies, 2024 |
16.2 Global Targeted Sequencing and Resequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here